US · HSCS
HeartSciences Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Southlake, TX 76092-1552
- Website
- heartsciences.com
Price · as of 2025-04-30
$1.99
Market cap 6.25M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $22.27 | +1,019.1% |
| Intrinsic Value(DCF) | $1.66 | -16.58% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $608.53 | +30,479.5% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | $0.00 | $3,659.40 | |||
| 2022 | $175.00 | $2,270.69 | $0.00 | $0.00 | $4,912.09 |
| 2023 | $88.20 | $369.82 | $0.00 | $0.00 | $4,258.17 |
| 2024 | $4.41 | $22.51 | $46.74 | $0.00 | $0.00 |
| 2025 | $4.16 | $22.27 | $0.00 | $0.00 | $608.53 |
AI valuation
Our deep-learning model estimates HeartSciences Inc.'s (HSCS) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $22.27
- Current price
- $1.99
- AI upside
- +1,019.1%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.66
-16.58% upside
Graham-Dodd
—
— upside
Graham Formula
$608.53
+30,479.5% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| HSCS | HeartSciences Inc. | $1.99 | 6.25M | +1,019% | -17% | — | +30,479% | -0.45 | 19.02 | 897.28 | -0.71 | — | -2.77 | -2884.71% | -192013.13% | -201499.52% | -233.04% | -360.16% | -127.72% | 14.55 | -16.69 | 0.59 | 0.30 | -0.23 | -5016.00% | -7661.00% | 2014.00% | -190.70% | -2.00 | -320.95% | 0.00% | 0.00% | 0.00% | -0.69 | -0.78 | 1331.10 | -31.62 |
| AMIX | Autonomix Medical, Inc. C… | $0.44 | 2.26M | — | — | — | — | -0.23 | 0.32 | — | 0.59 | — | 0.32 | 0.00% | — | — | -145.10% | 2283.35% | -118.77% | 0.00 | -65.84 | 5.63 | 5.35 | 0.83 | -6937.00% | — | 2407.00% | -316.49% | -4.84 | 1629.95% | 0.00% | 0.00% | 58.54% | 0.56 | 0.79 | — | -9.21 |
| BMRA | Biomerica, Inc. | $2.08 | 6.28M | +8,823% | -40% | — | — | -1.44 | 1.74 | 1.35 | -1.10 | -0.29 | 1.84 | 9.38% | -96.72% | -93.64% | -92.99% | -191.32% | -65.44% | 0.11 | — | 2.80 | 1.80 | 0.41 | 50000.00% | -192.00% | -2918.00% | -54.28% | -2.21 | -144.43% | 0.00% | 0.00% | 0.00% | -1.01 | -1.34 | 0.98 | -11.52 |
| MYNZ | Mainz Biomed B.V. | $0.76 | 3.11M | +29,917% | +195% | — | — | -0.25 | 0.90 | 6.08 | -0.13 | -0.02 | 1.79 | 64.31% | -2091.23% | -2421.80% | -465.82% | -559.63% | -151.15% | 0.54 | -17.39 | 1.32 | 1.08 | 0.15 | 128025.00% | -17.00% | -2724.00% | -319.32% | -2.87 | -519.21% | 0.00% | 0.00% | 61.01% | -0.13 | -0.14 | 2.76 | -13.59 |
| NRSN | NeuroSense Therapeutics L… | $0.91 | 22.42M | — | — | — | — | -2.06 | 8.14 | — | -1.79 | — | 8.14 | 0.00% | — | — | -2880.11% | 388.77% | -263.45% | 0.03 | -31.84 | 2.21 | 1.78 | 0.33 | -3373.00% | — | 2094.00% | -48.23% | -5.09 | 398.04% | 0.00% | 0.00% | 3.84% | -1.79 | -1.75 | — | -11.40 |
| PAVM | PAVmed Inc. | $10.08 | 5.41M | +10,627% | +918% | +5,945% | +35,854% | 0.23 | -2.66 | 2.21 | 1.26 | — | -2.66 | -101.60% | -1485.38% | 1328.58% | -100.94% | -2590.22% | 89.14% | -12.77 | -988.60 | 0.06 | 0.03 | 1.03 | -10541.00% | 2215.00% | -3571.00% | -507.27% | -0.95 | -1956.86% | 0.00% | 0.00% | 0.00% | -0.84 | -1.11 | 12.45 | -17.53 |
| SSKN | STRATA Skin Sciences, Inc… | $0.21 | 892.55K | +26,438% | +386% | — | — | -9.66 | 19.60 | 2.90 | -37.52 | — | -32.12 | 56.85% | -27.58% | -30.05% | -114.22% | -51.01% | -25.80% | 3.31 | -4.39 | 1.13 | 0.86 | -3.23 | -1613.00% | 61.00% | -7385.00% | -1.49% | 0.01 | -8.11% | 0.00% | 0.00% | 0.00% | -11.52 | -73.65 | 3.18 | -7.58 |
About HeartSciences Inc.
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
- CEO
- Andrew Simpson
- Employees
- 15
- Beta
- 2.54
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.66 ÷ $1.99) − 1 = -16.58% (DCF, example).